CME Webinar: Integrative BRCA 1 and 2 Diagnostics and Therapeutics

A CPD accredited CME webinar held by KACP on 6 May 2026, from 6:30pm EAT on Zoom, with support from AstraZeneca and Medics Management Services as event organiser. It treated BRCA 1 and 2 testing as interdisciplinary work, and looked at how the pathologist and the oncologist each shape what a result means for the patient. Its line was simple: Advancing Precision. Transforming Outcomes.

Talks

• Bridging Histopathology and Molecular Diagnostics: The Pathologist’s Central Role in BRCA 1 and 2 Testing. Dr. Allan Njau, Assistant Professor, Department of Pathology and Laboratory Medicine, Aga Khan University Hospital.
• From Biomarker to Bedside: The Oncologist’s Perspective on BRCA 1 and 2 Testing in Treatment Decision Making. Dr. Njoki Njiraini, Consultant Clinical Oncologist, Kenyatta National Hospital.

Moderator: Dr. Edwin Walong, Consultant Pathologist, Medical Educator and Senior Lecturer, Maseno University School of Medicine, Kisumu.